8 news items
Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates
AZN
CADL
LTRN
23 May 24
of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company
Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates
AZN
CADL
LTRN
23 May 24
of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection
ABVC
AMGN
CADL
15 May 24
liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection
ABVC
AMGN
CADL
15 May 24
liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
AZN
CADL
HALO
9 May 24
constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict
ogdwa1loa
AZN
CADL
HALO
9 May 24
constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict
s933kedioixbo8j1exmuwg0j4chlt84pjk4giv9v
AZN
CADL
HALO
9 May 24
liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our
z3peqtki 0qv
AZN
CADL
HALO
9 May 24
., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest
- Prev
- 1
- Next